CD8A and neoplasm: In the present study, we also discovered that CYPJ is highly expressed in LIHC, and the high level of CYPJ is associated with an increase in M1 TAMs and CD8+ T cells, suggesting that the upregulation of CYPJ is a protective factor that limits tumor progression.